ArticleNature and science of sleep2025
Prevalence and Factors Associated with Rapid Eye Movement-Related Obstructive Sleep Apnea in Patients with Narcolepsy.
Article in Nature and science of sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Sleep-disordered breathing and psychiatric comorbidities in narcolepsy: A 10-year retrospective study from Saudi Arabia.Sleep medicine: X · 2026Article
- "Phenotyping obstructive sleep apnea: a pathway to precision medicine".Sleep & breathing = Schlaf & Atmung · 2026Review
- Glymphatic dysfunction and its association with clinical symptom severity in narcolepsy type 1: a case-control DTI-ALPS study.BMC neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Data on the prevalence and correlates of rapid eye movement (REM)-related obstructive sleep apnea (REM-OSA) in narcolepsy remains limited. This study aimed to assess the prevalence and independent associated factors with OSA and REM-OSA in patients with narcolepsy, and to compare the distribution of REM-OSA between patients with narcolepsy and matched controls without narcolepsy. Patients and Methods: This retrospective study of a prospectively collected cohort included 190 adult patients with narcolepsy (narcolepsy type 1 [NT1] = 119, narcolepsy type 2 [NT2] = 71) who underwent polysomnography and multiple sleep latency test at the University Sleep Disorders Center, King Saud University Medical City, between January 2007 and February 2022. REM-OSA was defined as an apnea-hypopnea index (AHI) ≥5, AHI-REM/AHI-non-rapid eye movement (NREM) ≥2, AHI-NREM <8, and REM sleep duration >10.5 minutes. A total of 106 patients with narcolepsy were diagnosed with OSA. A control group of 122 patients with OSA but without narcolepsy, matched by age, sex, AHI, and BMI, was used for comparison. Logistic regression identified independent associated factors with OSA and REM-OSA. Results: OSA was diagnosed in 106 patients with narcolepsy (55.8%). REM-OSA was present in 26.4% of these cases, with a slightly higher prevalence in NT2 (30%) than in NT1 (24%). REM-OSA showed a trend toward higher prevalence in the narcolepsy group compared to controls (26.4% vs 17.2%, OR: 1.73, 95% CI: 0.91-3.27, p = 0.09). Male sex, BMI, and arousal index were independent correlates of OSA among patients with narcolepsy. REM-OSA was independently associated with arousal index and REM sleep duration. Conclusion: OSA and REM-OSA are common in patients with narcolepsy. REM-OSA was more prevalent in the narcolepsy group than in matched controls, suggesting a potential association between narcolepsy and REM-OSA that warrants investigation in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.